|
 |
 |
European BioPharmaceutical Review |
| |
|
European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.
With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.
|
|
 |
|
|
 |
 |
Industry Events |
 |
C21 BioVentures
25-27 May 2010, California, US
C21 BioVentures™(C21) is the leading conference where early stage innovators, investors and pharma partners come together to do the deals that will make 2010 the year of global partnering. C21 features private company presentations, pre-scheduled face-to-face partnering meetings, expert panels, workshops and three days of networking opportunities at an intimate world-class resort and spa.
More info >> |
|
 |
News and Press Releases |
 |
Thermo Fisher Scientific ‘Plate of the Month’ Trial Lets Life Scientists Try the World’s Most Rigid High-Throughput PCR Plate
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will offer life scientists the opportunity to use Thermo Scientific ABgene Diamond Ultra PCR Plates on a trial basis as their 'Plate of the Month' for March 2010. This ultra-rigid 384-well PCR plate ensures reliable performance on medium- to high-throughput robotic handling systems for a smooth and efficient workflow.
More info >> |
|
|